Royalty Pharma PLC (RPRX)

Last Closing Price: 53.55 (2026-05-21)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Royalty Pharma PLC (RPRX) had Net Income of $294.69M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$630.58M
Net Income
$294.69M
--
$630.58M
$67.54M
$563.04M
$-94.78M
$468.26M
$474.94M
$468.26M
$468.26M
$468.26M
$474.94M
$563.04M
$571.88M
436.79M
556.84M
$0.67
$0.67
Balance Sheet Financials
$1.43B
$16.54B
$18.39B
$19.82B
$535.68M
$8.58B
$9.34B
$9.88B
$9.94B
$9.01B
$9.94B
1.00B
Cash Flow Statement Financials
$718.23M
$-477.87M
$-272.67M
$618.70M
$586.39M
$-32.30M
$121.99M
$-222.34M
--
Fundamental Metrics & Ratios
2.66
--
--
0.46
0.90
100.00%
89.29%
89.29%
--
74.26%
46.73%
$265.87M
--
--
--
0.03
--
22.92
3.93
4.71%
5.20%
2.36%
2.53%
$9.90
$0.48
$1.29